应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
02487 科笛-B
休市中 04-19 16:08:35
6.730
-0.010
-0.15%
最高
6.860
最低
6.530
成交量
5.40万
今开
6.800
昨收
6.740
日振幅
4.90%
总市值
20.51亿
流通市值
20.51亿
总股本
3.05亿
成交额
35.95万
换手率
0.02%
流通股本
3.05亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
科笛-B(02487)维持“跑赢行业”评级,目标价12.7港元
中金公司 · 04-19 16:16
科笛-B(02487)维持“跑赢行业”评级,目标价12.7港元
科笛-B04月17日主力资金流出16万元 连续3日减仓
自选股智能写手 · 04-17 16:16
科笛-B04月17日主力资金流出16万元 连续3日减仓
科笛-B04月16日遭主力抛售57万元 环比增加307.14%
自选股智能写手 · 04-16
科笛-B04月16日遭主力抛售57万元 环比增加307.14%
科笛-B(02487)股价上升7.483%,现价港币$7.9
阿斯达克财经 · 04-09
科笛-B(02487)股价上升7.483%,现价港币$7.9
科笛-B(02487)下跌10.01%,报7.1元/股
金融界 · 04-02
科笛-B(02487)下跌10.01%,报7.1元/股
科笛-B(02487):毛发产品线表现强劲,多管线研发展现中长期成长空间
和讯网 · 04-02
科笛-B(02487):毛发产品线表现强劲,多管线研发展现中长期成长空间
科笛-B(02487)股价显著下跌10.773%,现价港币$7.04
阿斯达克财经 · 04-02
科笛-B(02487)股价显著下跌10.773%,现价港币$7.04
中金:维持科笛-B(02487)“跑赢行业”评级 目标价12.7港元
智通财经 · 04-02
中金:维持科笛-B(02487)“跑赢行业”评级 目标价12.7港元
科笛-B(02487)23年年报点评:优异商业化能力推动毛发&护肤管线持续增长,核心管线获批可期
信达证券 · 03-29
科笛-B(02487)23年年报点评:优异商业化能力推动毛发&护肤管线持续增长,核心管线获批可期
科笛-B(02487.HK)商业化为帆 创新作桨 迈向领先泛皮肤学平台型企业
方正证券 · 03-29
科笛-B(02487.HK)商业化为帆 创新作桨 迈向领先泛皮肤学平台型企业
科笛-B:将2024年全年收入指引从2亿元上调至2.8亿元
市场资讯 · 03-29
科笛-B:将2024年全年收入指引从2亿元上调至2.8亿元
科笛-B(02487)全年亏损2.5倍,收益增长1110.83%
和讯网 · 03-28
科笛-B(02487)全年亏损2.5倍,收益增长1110.83%
港股异动 | 科笛-B(02487)一度跌近10% 全年亏损同比扩大2.5倍 不派息
智通财经 · 03-28
港股异动 | 科笛-B(02487)一度跌近10% 全年亏损同比扩大2.5倍 不派息
科笛-B(02487)下跌11.25%,报7.81元/股
金融界 · 03-28
科笛-B(02487)下跌11.25%,报7.81元/股
《公司业绩》科笛-B(02487.HK)全年亏损扩至19.64亿人币
阿斯达克财经 · 03-27
《公司业绩》科笛-B(02487.HK)全年亏损扩至19.64亿人币
科笛-B(02487.HK)公布年度业绩 研发成本增长19.3%
格隆汇资讯 · 03-27
科笛-B(02487.HK)公布年度业绩 研发成本增长19.3%
科笛-B(02487)发布年度业绩 股东应占亏损19.64亿元 同比扩大253.3%
智通财经 · 03-27
科笛-B(02487)发布年度业绩 股东应占亏损19.64亿元 同比扩大253.3%
科笛-B(02487)上涨5.18%,报8.94元/股
金融界 · 03-27
科笛-B(02487)上涨5.18%,报8.94元/股
科笛-B(02487):CU-10101(外用新型小分子药剂)治疗特应性皮炎新药临床申请获国家药监局药品审评中心受理
智通财经网 · 03-27
科笛-B(02487):CU-10101(外用新型小分子药剂)治疗特应性皮炎新药临床申请获国家药监局药品审评中心受理
科笛-B(02487)上涨6.67%,报8.95元/股
金融界 · 03-25
科笛-B(02487)上涨6.67%,报8.95元/股
加载更多
公司概况
公司名称:
科笛-B
所属市场:
SEHK
上市日期:
--
主营业务:
科笛集团是一家主要从事皮肤学生物药物研发和制造的中国公司。该公司致力于开发全面的解决方案,以满足患者及消费者在广泛皮肤病治疗及护理市场中多样化需求。该公司主要从事其核心产品CU-20401的临床试验。该产品主要用于治疗颏下脂肪堆积。该公司在中国国内市场和海外市场开展其业务。
发行价格:
--
{"stockData":{"symbol":"02487","market":"HK","secType":"STK","nameCN":"科笛-B","latestPrice":6.73,"timestamp":1713514115032,"preClose":6.74,"halted":0,"volume":54000,"delay":0,"floatShares":304738625,"shares":304738625,"eps":-10.364127,"marketStatus":"休市中","marketStatusCode":7,"change":-0.01,"latestTime":"04-19 16:08:35","open":6.8,"high":6.86,"low":6.53,"amount":359522,"amplitude":0.048961,"askPrice":6.73,"askSize":1400,"bidPrice":6.69,"bidSize":1000,"shortable":3,"etf":0,"ttmEps":-10.364127381010556,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1713749400000},"adr":0,"listingDate":1686499200000,"adjPreClose":6.74,"openAndCloseTimeList":[[1713490200000,1713499200000],[1713502800000,1713513600000]],"volumeRatio":0.2119642016015073,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02487","defaultTab":"news","newsList":[{"id":"2428680501","title":"科笛-B(02487)维持“跑赢行业”评级,目标价12.7港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2428680501","media":"中金公司","top":-1,"share":"https://www.laohu8.com/m/news/2428680501?lang=zh_cn&edition=full","pubTime":"2024-04-19 16:16","pubTimestamp":1713514602,"startTime":"0","endTime":"0","summary":"23年公司毛利率同比-18.2ppt至51.6%,主因尚处培育初期、毛利率偏低的护肤品牌欧玛收入占比提升。最终公司净亏损19.64亿元,调整后的经营性净亏损为3.29亿元,净亏损率有所收窄。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404191630288794c07c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404191630288794c07c&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428576393","title":"科笛-B04月17日主力资金流出16万元 连续3日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2428576393","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428576393?lang=zh_cn&edition=full","pubTime":"2024-04-17 16:16","pubTimestamp":1713341797,"startTime":"0","endTime":"0","summary":"04月17日, 科笛-B股价跌1.47%,报收6.70元,成交金额139万元,换手率0.07%,振幅6.62%,量比0.75。科笛-B今日主力资金净流出16万元,连续3日净流出,上一交易日主力净流出57万元,今日环比减少71.93%。该股近5个交易日下跌7.45%,主力资金累计净流出86万元;近20日主力资金累计净流入41万元,其中净流入天数为3日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404171617058787fd2a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404171617058787fd2a&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427981780","title":"科笛-B04月16日遭主力抛售57万元 环比增加307.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2427981780","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427981780?lang=zh_cn&edition=full","pubTime":"2024-04-16 16:17","pubTimestamp":1713255424,"startTime":"0","endTime":"0","summary":"04月16日, 科笛-B股价跌1.45%,报收6.80元,成交金额206万元,换手率0.10%,振幅6.23%,量比1.20。科笛-B今日主力资金净流出57万元,上一交易日主力净流出14万元,今日环比增加307.14%。该股近5个交易日下跌7.61%,主力资金累计净流出70万元;近20日主力资金累计净流入124万元,其中净流入天数为4日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404161618358b2994ae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404161618358b2994ae&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426871901","title":"科笛-B(02487)股价上升7.483%,现价港币$7.9","url":"https://stock-news.laohu8.com/highlight/detail?id=2426871901","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2426871901?lang=zh_cn&edition=full","pubTime":"2024-04-09 09:35","pubTimestamp":1712626500,"startTime":"0","endTime":"0","summary":"[上升股]科笛-B(02487) 股价在上午09:35比前收市价上升7.483%,现股价为港币$7.9。至目前为止,今日最高价为$7.9,而最低价为$7.19。总成交量为2.4万股,总成交金额为港币$18.036万。","market":"fut","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180416150419953_s.png","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180416150419953_s.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR240409792/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2424056778","title":"科笛-B(02487)下跌10.01%,报7.1元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2424056778","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2424056778?lang=zh_cn&edition=full","pubTime":"2024-04-02 13:39","pubTimestamp":1712036347,"startTime":"0","endTime":"0","summary":"4月2日,科笛-B(02487)盘中下跌10.01%,截至13:39,报7.1元/股,成交317.06万元。科笛集团是一家专注于皮肤学的生物制药公司,主要业务是研发创新和全面的皮肤病治疗及护理解决方案。公司的目标是成为国际领先的研发型皮肤学平台,为消费者和患者提供创新、安全、有效的皮肤及脱发疾病等全方位的专业解决方案。截至2023年年报,科笛-B营业总收入1.38亿元、净利润-19.64亿元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/04/02133940090862.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2424487058","title":"科笛-B(02487):毛发产品线表现强劲,多管线研发展现中长期成长空间","url":"https://stock-news.laohu8.com/highlight/detail?id=2424487058","media":"和讯网","top":-1,"share":"https://www.laohu8.com/m/news/2424487058?lang=zh_cn&edition=full","pubTime":"2024-04-02 11:57","pubTimestamp":1712030250,"startTime":"0","endTime":"0","summary":"该公司的毛发产品线表现出快速增长,收入占比约为70%。然而,产品结构变化导致公司的毛利率阶段性下降,但规模效应带动净亏损率收窄。此外,该公司多管线研发进展顺利,展现了中长期成长空间。中金看好公司在皮肤管理平台方面的中长期成长空间。总体而言,中金维持了对科笛-B的“跑赢行业”评级,并上调了2024年收入预测。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404021251048ae6dad5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404021251048ae6dad5&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2424808470","title":"科笛-B(02487)股价显著下跌10.773%,现价港币$7.04","url":"https://stock-news.laohu8.com/highlight/detail?id=2424808470","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2424808470?lang=zh_cn&edition=full","pubTime":"2024-04-02 09:40","pubTimestamp":1712022000,"startTime":"0","endTime":"0","summary":"[下跌股]科笛-B(02487) 股价在上午09:40比前收市价显著下跌10.773%,现股价为港币$7.04。至目前为止,今日最高价为$7.8,而最低价为$6.94。总成交量为8.82万股,总成交金额为港币$63.522万。","market":"fut","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180205152742524_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180205152742524_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD240402600/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2424851150","title":"中金:维持科笛-B(02487)“跑赢行业”评级 目标价12.7港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2424851150","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2424851150?lang=zh_cn&edition=full","pubTime":"2024-04-02 09:13","pubTimestamp":1712020381,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,中金发布研究报告称,维持科笛-B“跑赢行业”评级,考虑到公司商业化进程超预期,上调2024年收入预测22%至2.8亿元,维持2025年收入预测;同时考虑到品牌培育期成本及费用投放增加,维持2024-25年盈利预测,目标价12.7港元。最终公司净亏损19.64亿元,调整后的经营性净亏损为3.29亿元,净亏损率有所收窄。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1097532.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2423545424","title":"科笛-B(02487)23年年报点评:优异商业化能力推动毛发&护肤管线持续增长,核心管线获批可期","url":"https://stock-news.laohu8.com/highlight/detail?id=2423545424","media":"信达证券","top":-1,"share":"https://www.laohu8.com/m/news/2423545424?lang=zh_cn&edition=full","pubTime":"2024-03-29 18:17","pubTimestamp":1711707424,"startTime":"0","endTime":"0","summary":"优异商业化能力推动公司毛发&护肤品管线快速放量。在研管线稳步推进,重磅管线获批可期。2023年净亏损部分源自一次性因素影响。港股通持股不断增长,关注度持续提升。考虑到当前港股通出通考核要求为:定期调整考察截至日前12个月月末平均市值低于40亿港元,公司23年7月至24年3月月末平均市值约49亿港元,24年4-6月月末平均市值不低于13.3亿港元即可保在通内,我们预计24年出通概率较小。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403291830288b71d4f6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403291830288b71d4f6&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2423843925","title":"科笛-B(02487.HK)商业化为帆 创新作桨 迈向领先泛皮肤学平台型企业","url":"https://stock-news.laohu8.com/highlight/detail?id=2423843925","media":"方正证券","top":-1,"share":"https://www.laohu8.com/m/news/2423843925?lang=zh_cn&edition=full","pubTime":"2024-03-29 15:51","pubTimestamp":1711698695,"startTime":"0","endTime":"0","summary":"④未来公司全面的管线布局和深厚的研发储备将驱动公司迈向领先泛皮肤学平台型企业。预计2024-2026年收入约2.83/5.9/10.02亿元,维持“推荐”评级。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403291551408b71230c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403291551408b71230c&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2423748551","title":"科笛-B:将2024年全年收入指引从2亿元上调至2.8亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2423748551","media":"市场资讯","top":-1,"share":"https://www.laohu8.com/m/news/2423748551?lang=zh_cn&edition=full","pubTime":"2024-03-29 08:15","pubTimestamp":1711671300,"startTime":"0","endTime":"0","summary":"来源 Gangtise投研管理层宣布,将2024年全年收入指引从2亿元上调至2.8亿元,其中毛发管线预计收入1.8亿元。复购率是公司最重视的销售指标之一,毛发产品的复购率已经从2023年初的20%增长到目前的稳态30%以上,最新一周的复购率已经超过38%。责任编辑:王其霖","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403290816227a4feff9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403290816227a4feff9&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422519180","title":"科笛-B(02487)全年亏损2.5倍,收益增长1110.83%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422519180","media":"和讯网","top":-1,"share":"https://www.laohu8.com/m/news/2422519180?lang=zh_cn&edition=full","pubTime":"2024-03-28 12:25","pubTimestamp":1711599945,"startTime":"0","endTime":"0","summary":"快讯正文港股异动 | 科笛-B一度跌近10% 全年亏损同比扩大2.5倍 不派息科笛-B今日开盘后一度下跌近10%,截至目前,下跌5.8%,报8.29港元,成交额599.58万港元。据悉,科笛-B发布了2023年度业绩,该集团在该期间实现收益1.38亿元,同比增长1110.83%。然而,股东应占亏损达到19.64亿元,同比扩大253.3%。此外,公司的毛利率从截至2022年12月31日的69.8%下降到2023年同期的51.6%。每股基本亏损为9.6元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403281322208b6c550e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403281322208b6c550e&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422907344","title":"港股异动 | 科笛-B(02487)一度跌近10% 全年亏损同比扩大2.5倍 不派息","url":"https://stock-news.laohu8.com/highlight/detail?id=2422907344","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2422907344?lang=zh_cn&edition=full","pubTime":"2024-03-28 10:52","pubTimestamp":1711594357,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,科笛-B(02487)早盘一度跌近10%,截至发稿,跌5.8%,报8.29港元,成交额599.58万港元。消息面上,科笛发布2023年度业绩,该集团期内取得收益1.38亿元(人民币,下同),同比增加1110.83%;股东应占亏损19.64亿元,同比扩大253.3%;此外,公司的毛利率由截至2022年12月31日止年度的69.8%降至2023年同期的51.6%,每股基本亏损9.6元。不派息。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1094429.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2422905223","title":"科笛-B(02487)下跌11.25%,报7.81元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2422905223","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2422905223?lang=zh_cn&edition=full","pubTime":"2024-03-28 09:38","pubTimestamp":1711589888,"startTime":"0","endTime":"0","summary":"3月28日,科笛-B(02487)盘中下跌11.25%,截至09:38,报7.81元/股,成交246.56万元。科笛集团是一家专注于皮肤学的生物制药公司,主要业务是研发创新和全面的皮肤病治疗及护理解决方案。公司的目标是成为国际领先的研发型皮肤学平台,为消费者和患者提供创新、安全、有效的皮肤及脱发疾病等全方位的专业解决方案。截至2023年年报,科笛-B营业总收入1.38亿元、净利润-19.64亿元。3月27日,2023财年年报归属股东应占溢利-19.64亿人民币,同比下降253.3%,基本每股收益-9.6人民币。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/03/28093840029329.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2422833969","title":"《公司业绩》科笛-B(02487.HK)全年亏损扩至19.64亿人币","url":"https://stock-news.laohu8.com/highlight/detail?id=2422833969","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2422833969?lang=zh_cn&edition=full","pubTime":"2024-03-27 18:16","pubTimestamp":1711534560,"startTime":"0","endTime":"0","summary":"科笛-B(02487.HK) 公布截至去年12月底止全年业绩,营业额1.38亿元人民币(下同),按年升1,110.8%。亏损扩大至19.64亿元,上年同期蚀5.56亿元;每股亏损9.6元。不派息。(ad/da)(港股报价延迟最少十五分钟。沽空资料截至 2024-03-27 16:25。)过往派息公布日期派息事项派息内容2023/08/29中期业绩无派息AASTOCKS新闻","market":"fut","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20230602115203039_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20230602115203039_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1337772/latest-news/AAFN","is_publish_highlight":false,"gpt_icon":0},{"id":"2422667679","title":"科笛-B(02487.HK)公布年度业绩 研发成本增长19.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422667679","media":"格隆汇资讯","top":-1,"share":"https://www.laohu8.com/m/news/2422667679?lang=zh_cn&edition=full","pubTime":"2024-03-27 18:13","pubTimestamp":1711534412,"startTime":"0","endTime":"0","summary":"格隆汇3月27日丨科笛-B发布公告,截至2023年12月31日止年度,公司收益由上年度的人民币11.4百万元增加1,110.8%至人民币137.6百万元,主要是由于毛发疾病及护理产品及日常护肤产品的销量增加。截至2023年12月31日止年度,公司录得亏损人民币1,963.8百万元,较上年度的人民币555.8百万元增加人民币1,408.0百万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403271814178b694fa9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403271814178b694fa9&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422965496","title":"科笛-B(02487)发布年度业绩 股东应占亏损19.64亿元 同比扩大253.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422965496","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2422965496?lang=zh_cn&edition=full","pubTime":"2024-03-27 18:09","pubTimestamp":1711534187,"startTime":"0","endTime":"0","summary":"智通财经APP讯,科笛-B(02487)发布截至2023年12月31日止年度业绩,该集团期内取得收益1.38亿元(人民币,下同),同比增加1110.83%;股东应占亏损19.64亿元,同比扩大253.3%;每股基本亏损9.6元。公告称,收入增加主要是由于毛发疾病及护理产品及日常护肤产品的销量增加。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403271811188b694d55&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403271811188b694d55&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422601883","title":"科笛-B(02487)上涨5.18%,报8.94元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2422601883","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2422601883?lang=zh_cn&edition=full","pubTime":"2024-03-27 09:32","pubTimestamp":1711503174,"startTime":"0","endTime":"0","summary":"3月27日,科笛-B(02487)盘中上涨5.18%,截至09:32,报8.94元/股,成交110.3万元。科笛集团是一家专注于皮肤学的生物制药公司,主要业务是研发创新和全面的皮肤病治疗及护理解决方案。公司的目标是成为国际领先的研发型皮肤学平台,为消费者和患者提供创新、安全、有效的皮肤及脱发疾病等全方位的专业解决方案。截至2023年中报,科笛-B营业总收入3434.3万元、净利润-16.4亿元。3月27日,科笛-B披露2023财年年报。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/03/27093240008631.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2422367676","title":"科笛-B(02487):CU-10101(外用新型小分子药剂)治疗特应性皮炎新药临床申请获国家药监局药品审评中心受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2422367676","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2422367676?lang=zh_cn&edition=full","pubTime":"2024-03-27 06:43","pubTimestamp":1711493001,"startTime":"0","endTime":"0","summary":"智通财经APP讯,科笛-B 发布公告,集团的CU-10101,用于治疗轻度至中度特应性皮炎的新药临床试验申请获得中华人民共和国国家药品监督管理局药品审评中心受理。CU-10101是一种适用于治疗轻度至中度特应性皮炎的非激素、小分子药物。CU-10101的非激素特性可减轻皮质类固醇相关的副作用及限制,其局部外用配方可使药物直接到达病症区域。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1093028.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2422537158","title":"科笛-B(02487)上涨6.67%,报8.95元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2422537158","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2422537158?lang=zh_cn&edition=full","pubTime":"2024-03-25 11:31","pubTimestamp":1711337512,"startTime":"0","endTime":"0","summary":"3月25日,科笛-B(02487)盘中上涨6.67%,截至11:31,报8.95元/股,成交583.84万元。科笛集团是一家专注于皮肤学的生物制药公司,主要业务是研发创新和全面的皮肤病治疗及护理解决方案。公司的目标是成为国际领先的研发型皮肤学平台,为消费者和患者提供创新、安全、有效的皮肤及脱发疾病等全方位的专业解决方案。截至2023年中报,科笛-B营业总收入3434.3万元、净利润-16.4亿元。3月27日,科笛-B将披露2023财年年报。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/03/25113139974136.shtml","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cutiatx.com","stockEarnings":[{"period":"1week","weight":-0.0467},{"period":"1month","weight":-0.2017},{"period":"3month","weight":0.006},{"period":"6month","weight":-0.6833},{"period":"1year","weight":-0.692},{"period":"ytd","weight":-0.3871}],"compareEarnings":[{"period":"1week","weight":-0.0298},{"period":"1month","weight":-0.0193},{"period":"3month","weight":0.0598},{"period":"6month","weight":-0.0552},{"period":"1year","weight":-0.2046},{"period":"ytd","weight":-0.0483}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"科笛集团是一家主要从事皮肤学生物药物研发和制造的中国公司。该公司致力于开发全面的解决方案,以满足患者及消费者在广泛皮肤病治疗及护理市场中多样化需求。该公司主要从事其核心产品CU-20401的临床试验。该产品主要用于治疗颏下脂肪堆积。该公司在中国国内市场和海外市场开展其业务。","exchange":"SEHK","name":"科笛-B","nameEN":"CUTIA-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"科笛-B(02487)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供科笛-B(02487)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"科笛-B,02487,科笛-B股票,科笛-B股票老虎,科笛-B股票老虎国际,科笛-B行情,科笛-B股票行情,科笛-B股价,科笛-B股市,科笛-B股票价格,科笛-B股票交易,科笛-B股票购买,科笛-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"科笛-B(02487)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供科笛-B(02487)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}